Clinical Quiz: HCV DAA Treatment After Solid Organ Transplantation

Since 2013, the Infectious Diseases Society of America and the American Association for the Study of Liver Diseases have worked together to develop evidence-based guidance for the diagnosis, management, and treatment of hepatitis C virus (HCV) infection.

This update to the previous 2020 guidelines was released in 2023 and reflects our current understanding of the infection with timely, evidence-based guidance spotlighting major changes related to screening, organ transplantation, and expanded treatment options for children and adolescents.

Test your knowledge of the 2023 HCV guidance update below:

When should treatment be initiated for HCV-uninfected recipients of liver grafts from HCV-viremic donors using glecaprevir/pibrentasvir?

Reference:

1. ^{Bhattacharya D, Aronsohn A, Price J, Lo Re V; AASLD-IDSA HCV Guidance Panel. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis. Published online May 25, 2023. doi:10.1093/cid/ciad319}

Editors' note: Artificial intelligence aided in the creation of this content.